Role of statins in the treatment of chronic hepatitis C virus infection.

Journal of the Egyptian Society of Parasitology

Volumn 42, Issue 3, 2012, Pages 535-540

  Abd Eldaem, Ashraf A ^a   Azmy, Mohammed K ^b   Ahmad, Youssef K ^b   Badr, Gamal A ^b   Houssein, Mousa A ^b   El Dahshan, Tarek ^b  

^a AL AZHAR UNIVERSITY   (Egypt)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDOLE DERIVATIVE; MACROGOL DERIVATIVE; MONOUNSATURATED FATTY ACID; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; RIBAVIRIN; VIRUS RNA;

ADULT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMAN; LIVER; MALE; MIDDLE AGED; PHYSIOLOGY; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 84891730762     PISSN: 11100583     EISSN: None     Source Type: Journal    
DOI: 10.12816/0006339     Document Type: Article

References (0)